Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (31-40 of 490) with videos related to

Pageof 49
Sort By:
Alimentary Pharmacology & Therapeutics|September 23, 2021
Review article: therapeutic aspects of bile acid signalling in the gut-liver axisBenedikt Simbrunner, Michael Trauner, Thomas Reiberger
Hepatology (Baltimore, Md.)|April 10, 2023
Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Thomas Reiberger, Michael Trauner
Journal of Hepatology|August 4, 2025
Non-acute decompensation: ready for clinical practice?Georg Kramer, Thomas Reiberger, Cristina Ripoll
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2021
ReplyMathias Jachs, Thomas Reiberger, Mattias Mandorfer
JHEP Reports : Innovation in Hepatology|December 6, 2024
Mechanisms and implications of recompensation in cirrhosisSalvatore Piano, Thomas Reiberger, Jaime Bosch
Journal of Hepatology|June 5, 2024
Does encephalopathy with early onset after TIPS impact on mortality?Lukas Hartl, Andrea Kornfehl, Thomas Reiberger
Wiener Klinische Wochenschrift|October 29, 2025
Reply to: comment on "Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary center"Marlene Hintersteininger, Thomas Reiberger, Lukas Hartl
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2022
ReplyGeorg Semmler, Thomas Reiberger, Bernhard Scheiner
Journal of Hepatology|March 23, 2023
Reply to: "3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta"Mathias Jachs, Mattias Mandorfer, Thomas Reiberger
Journal of Hepatology|January 26, 2021
Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"Dalila Costa, Benedikt Simbrunner, Thomas Reiberger
Pageof 49

Showing results (31-40 of 490) with videos related to

Sort By:
Pageof 49
Alimentary Pharmacology & Therapeutics|September 23, 2021
Review article: therapeutic aspects of bile acid signalling in the gut-liver axisBenedikt Simbrunner, Michael Trauner, Thomas Reiberger
Hepatology (Baltimore, Md.)|April 10, 2023
Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Thomas Reiberger, Michael Trauner
Journal of Hepatology|August 4, 2025
Non-acute decompensation: ready for clinical practice?Georg Kramer, Thomas Reiberger, Cristina Ripoll
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2021
ReplyMathias Jachs, Thomas Reiberger, Mattias Mandorfer
JHEP Reports : Innovation in Hepatology|December 6, 2024
Mechanisms and implications of recompensation in cirrhosisSalvatore Piano, Thomas Reiberger, Jaime Bosch
Journal of Hepatology|June 5, 2024
Does encephalopathy with early onset after TIPS impact on mortality?Lukas Hartl, Andrea Kornfehl, Thomas Reiberger
Wiener Klinische Wochenschrift|October 29, 2025
Reply to: comment on "Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary center"Marlene Hintersteininger, Thomas Reiberger, Lukas Hartl
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2022
ReplyGeorg Semmler, Thomas Reiberger, Bernhard Scheiner
Journal of Hepatology|March 23, 2023
Reply to: "3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta"Mathias Jachs, Mattias Mandorfer, Thomas Reiberger
Journal of Hepatology|January 26, 2021
Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"Dalila Costa, Benedikt Simbrunner, Thomas Reiberger
Pageof 49